http://blog.garymoller.com/search/label/fosamax-lawsuits
I use the phrase "bone-sparing" with extreme cynicism because just two of this class of drug are blamed for causing 31,500 femur and hip fractures in the USA alone!
Bear in mind that less than 10% of adverse reactions ever get reported.
Read on and read the links I have provided. As I said in an earlier article, "You would have to be nuts to be taking these".
Acute Phase Reactions
Renal Reactions
- dehydration
- pre-existing renal impairment
- multiple cycles of zoledronic acid or other bisphosphonates
- concomitant use of nephrotoxic drugs
- a shorter infusion time than recommended.
References
- Reid IR, Gamble GD, Mesenbrink P, et al. 2010. Characterization of and risk factors for the acute-phase response after zoledronic acid. The Journal of Clinical Endocrinology and Metabolism 95: 4380–4387.
- Tanvetyanon T, Stiff PJ. 2006. Management of the adverse effects associated with intravenous bisphosphonates. Annals of oncology 17: 897–907.
- Medsafe. 2011. Reminder: Keeping an eye on bisphosphonates. Prescriber Update 32(3): 24. URL: www.medsafe.govt.nz/profs/PUArticles/BisphosphonatesSept2011.htm (accessed 19 May 2015).
- Attivi D, Kosmalski G, Zeghmouli C, et al. 2014. Effect of intravenous hydration in patients receiving bisphosphonate therapy. International Journal of Clinical Pharmacy 36: 1277–1281.
- Novartis New Zealand Limited. 2014. Zometa Data Sheet. 21 October 2014. URL: www.medsafe.govt.nz/profs/datasheet/z/Zometaconcinf.pdf (accessed 19 May 2015).
- Novartis New Zealand Limited. 2014. Aclasta Data Sheet. 8 October 2014. URL: www.medsafe.govt.nz/profs/datasheet/a/Aclastainf.pdf (accessed 19 May 2015).
http://medsafe.govt.nz/profs/PUArticles/June2015/June2015ZoledronicAcid.htm
Further reading:
http://blog.garymoller.com/search/label/fosamax












